Rationale, design, and baseline characteristics of the Salt Substitute and Stroke Study (SSaSS)—A large-scale cluster randomized controlled trial

Bruce Neal(UNSW Sydney), Yangfeng Wu(Beijing Haidian Hospital), Liping Huang(UNSW Sydney), Jingpu Shi(First Hospital of China Medical University), Darwin R. Labarthe(UK Health Forum), Sandrine Stepien(The University of Sydney), Paul Elliott(Ipsen (France)), Maoyi Tian(Harbin Medical University), Lijing L. Yan(Duke University), Yuhong Zhang(Central Hospital of Zibo), Ruijuan Zhang(Xi'an Jiaotong University), Xiangxian Feng(Changzhi Medical College), Jianxin Zhang(Hebei Provincial Center for Disease Control and Prevention), Xuejun Yin(George Institute for Global Health), Zhixin Hao(Chinese Academy of Medical Sciences & Peking Union Medical College), Nicole Li(George Institute for Global Health)
American Heart Journal
March 13, 2017
10.1016/j.ahj.2017.02.033
Cited by 82

Related Papers

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019
|Journal of the American College of Cardiology|2020|11.4k
Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015
|The Lancet|2016|7.8k
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
|New England Journal of Medicine|2017|7.7k
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k